Edition:
United States

Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

3.91USD
4:00pm EDT
Change (% chg)

$0.07 (+1.82%)
Prev Close
$3.84
Open
$3.90
Day's High
$3.96
Day's Low
$3.73
Volume
397,965
Avg. Vol
196,873
52-wk High
$5.69
52-wk Low
$2.03

Chart for

About

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $469.48
Shares Outstanding(Mil.): 131.88
Dividend: --
Yield (%): --

Financials

  PACB.OQ Industry Sector
P/E (TTM): -- 37.52 33.88
EPS (TTM): -0.83 -- --
ROI: -79.72 8.74 13.21
ROE: -107.61 12.63 15.18

BRIEF-Pacific Biosciences Posts Favorable Outcome In UK And German Patent Litigation Against Oxford Nanopore

* PACIFIC BIOSCIENCES ANNOUNCES FAVORABLE OUTCOME IN UK AND GERMAN PATENT LITIGATION AGAINST OXFORD NANOPORE

May 08 2018

BRIEF-Pacific Biosciences Of California Reports Qtrly Loss Per Share Of $0.20

* PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 02 2018

BRIEF-Pacific Biosciences Announces Ten-Unit Sequel System Order For Annoroad

* PACIFIC BIOSCIENCES ANNOUNCES TEN-UNIT SEQUEL SYSTEM ORDER FOR ANNOROAD Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

Mar 27 2018

BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling

* PACIFIC BIOSCIENCES PREVAILS IN PATENT ELIGIBILITY RULING AGAINST OXFORD NANOPORE

Mar 22 2018

BRIEF-Pacific Biosciences Of California Prices Public Offering

* PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

Feb 13 2018

BRIEF-Pacific Biosciences Of California Announces Proposed Public Offering Of Common Stock

* PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Feb 12 2018

Competitors

  Price Chg
Illumina, Inc. (ILMN.OQ) $287.65 +1.91
Thermo Fisher Scientific Inc. (TMO.N) $208.80 -1.13

Earnings vs. Estimates